Germany
August 11, 2005
Source:
Deutsche Welle
via
Checkbiotech
American biotech firms want to use
legal action to force Germany to approve their genetically
modified maize for cultivation.
The America seed companies
Monsanto and Pioneer are trying to get provisional approval to
cultivate their pest-resistant maize, Mon 810, in Germany,
according to German consumer protection authorities.
But Alexander Müller of the consumer protection office says he
doesn't believe that Mon 810 can be legally approved as seed.
"It is not allowed under European law," he told the German
public broadcaster ARD. For the past seven years, Mon 810 has
been approved in the EU only as feed and as food. Cultivation of
the crop was explicitly excluded.
But the EU Commission, in contrast, says that Mon 810, also as
seed, is legal and must be allowed to be used in Germany, a
commission spokeswoman told ARD. The maize has been included in
the collective EU catalogue of allowable imports since 2004,
authorizing its use.
"It must be allowed to be imported into Germany," a spokeswoman
for the European Commission said.
Spanish use contentious maize
Last year, the EU Commission approved 17 types of maize in the
Mon 810 line after Spain experienced no problems with its
cultivation. But according to Müller, that approval might need
to be examined by European Court of Justice, Müller said. "If
our legal interpretation is correct, the Spanish will have to
see if their approval was legitimate."
The environmental watchdog group Greenpeace is one of the groups
opposed to the cultivation of Mon 810, saying that the crop can
harm butterflies. Greece, Austria, Poland and Hungary have not
given the go-ahead for the cultivation of Mon 810. Still, German
regulators have been testing the line for several years.
Regardless of the legal fight, the crop is already being
cultivated in Germany on a trial basis.
EU still wary
On a global scale, the use of genetically modified (GM) crops is
increasing, with the world’s overall area of approved GM crops
now at well over 80 million hectares (8 billion acres). So far,
maize, soybeans, rapeseed and cotton account for the bulk of
biotech crops on the market.
But most EU member countries, including Germany, have remained
extremely wary of biotech crop technologies. Concerns include
giving multinational corporations control of basic food products
through gene patents, the possibility of spreading allergens
through genetic manipulations and the spread of resistance to
antibiotics used in genetic engineering -- concerns that are
shared by non-governmental organizations such as Greenpeace.
"There's not much research done on the risks of GM plants on the
environment or on human health," Ulrike Brendel, a Greenpeace
spokesperson for the GM issue, told Dw-World.
Germany approved the growing of genetically modified crops in
Germany last year under a controversial law that imposes strict
penalties for possible violations of food-safety regulations.
The law also requires the labeling of foodstuffs produced with
genetically modified organisms and allows conventional farmers
to file for damages if other growers contaminating their fields
with GM seeds.
© Deutsche Welle 2005
|